FindTrial
Sign In

Effect of Intravenous Lignocaine, Dexmedetomidine and their combination on pulse,blood pressure and oxygen saturation during operation, pain after operation and quality of recovery in patients undergoing uterus removal operation by robot

Effect of Intravenous Lignocaine, Dexmedetomidine and their Combination on Intraoperative Haemodynamics, Postoperative Pain, and Quality of Recovery In Patients Undergoing Robotic Abdominal Hysterectomy: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021323
Enrollment
120
Registered
2019-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N958- Other specified menopausal and perimenopausal disorders

Interventions

Intervention1: Effect of Intravenous Lignocaine, Dexmedetomidine and their Combination on Intraoperative Haemodynamics, Postoperative Pain, and Quality of Recovery In Patients Undergoing Robotic Abdom

Sponsors

AIIMS RISHIKESH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female patients aged 30-65 years, 2.ASA grade I & II 3.Patients undergoing elective Robotic Abdominal Hysterectomy under general anaesthesia will be selected

Exclusion criteria

Exclusion criteria: 1.ASA grade III & IV patients 2.Age >65 years 3.BMI >35kg/m2 4.Allergy to local anaesthetic agents 5.History of use of opioid, analgesics and psychotropic drugs and beta blockers, substance abuse preoperatively 6.Uncontrolled hypertension, A-V conduction block, history of sleep apnoea

Design outcomes

Primary

MeasureTime frame
To assess post operative pain as measured by VASTimepoint: 4 hours after surgery—

Secondary

MeasureTime frame
1.Time to first bowel sounds and flatus 2.Intraoperative consumption of propofol, fentanyl and vecuronium 3.Postoperative fentanyl requirement 4.QoR15 score on day 1,2 and on day of dischargeTimepoint: DAY 0,1,2 AND ON THE DAY OF DISCHARGE—

Countries

India

Contacts

Public ContactDr SANJAY AGRAWAL

ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS) RISHIKESH

docagrawal72@yahoo.in97671712630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026